We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bayer Releases Automated Serum HER-2/Neu Test

By HospiMedica staff writers
Posted on 28 Oct 2003
An automated assay for the quantitative measurement of the oncoprotein HER-2/neu in blood serum is now available from Bayer Diagnostics (Tarrytown, NY, USA) for use on the company's Advia Centaur immunoassay system.

The assay is intended to be used as a complement to conventional tissue testing such as immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) by providing a real-time picture of a patient's HER-2/neu levels via a simple blood test. More...
This helps oncologists to make better therapy decisions and to monitor the therapy's effects. Studies have shown that persistently rising HER-2/neu values may be associated with aggressive cancer and poor response to therapy, while decreasing levels may be indicative of effective therapy.

"It simply is not practical to monitor the success of therapy by continuously taking biopsies of metastatic tumors,” noted Dr. Roy Sherwood, consultant clinical scientist at King's College Hospital in London (UK). "However, availability of the serum assay allows you to monitor treatment efficacy and adjust dosage as appropriate, as well as being potentially diagnostic in cases where fresh tissue is not available.”





Related Links:
Bayer Diagnostics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.